The Annual General Meeting in
Adoption of the annual report and the auditor's report
The Annual General Meeting resolved to approve the profit and loss statement and the balance sheet regarding the parent Company and the Group, appropriation of the profit in accordance with the Board of Directors proposal and not to distribute any dividends for the financial year 2022, as well as to discharge the CEO and Board members from liability.
Election of Board members
As members of the Board of Directors it was resolved to re-elect of
Audit Committee:
Investment Committee:
Remuneration Committee:
Election of auditor
The Annual General Meeting resolved to re-elect
Resolution on a Long Term Incentive Program
The Annual General Meeting resolved to introduce an incentive program (the "P08") for employees of the Group. P08 consists of stock options intended for the employees of the Group employed in
The options shall be granted to the participants free of charge. Depending on the fulfilment of the performance condition of the Group, each Stock Option entitles the employee to acquire one share of
The purpose of P08 is to improve the opportunity for retaining and recruiting competent personnel to the Company and increasing the motivation amongst the employees.
Resolution to authorise the Board of Directors to resolve on directed issue of Series C shares and hedging measures in the form of repurchase and transfer own shares
The Annual General Meeting resolved, in accordance with the Board of Directors' proposal to authorise the Board of Directors to resolve on a new issue of a maximum of 7,341,000 Series C shares, each with a quota value of
The purpose of the authorisations and the reason for the deviation from the shareholders' preferential rights in the event of implementation of the issue is to ensure delivery of shares to participants in P08 and in order to on terms of liquidity to secure social security charges.
Resolution on authorisation for the Board of Directors to resolve on issues of shares and/or convertible bonds
The Annual General Meeting resolved to authorise the Board of Directors to, on one or several occasions during the period until the next Annual General Meeting, with or without deviation from the shareholder's preferential rights, resolve on share issues and/or issues of convertible bonds that involve the issue of or conversion to a maximum of 42,000,000 ordinary shares, corresponding to a dilution of approximately 15.2 percent of the share capital and the voting rights, based on the current number of shares in the Company. Payment for subscribed shares and/or convertible bonds shall be made in cash, in kind or by way of set-off.
The purpose of the authorisation and the reason for the deviation from the shareholders' preferential rights, is to give the Board of Directors flexibility in the work to secure that the Company in a time-efficient and appropriate way can achieve capital for financing of the operation and to enable continued expansion both organically as well as through acquisitions, alternatively to increase the number of shareholders with one or several owners of strategical importance for the Company. The issuance of shares and/or convertible bonds under this authorisation shall be made at a subscription price according to the prevailing market conditions at the time of the issuance of the shares and/or convertible bonds.
For more information, please contact:
CEO,
Email: anders.storm@sivers-semiconductors.com
Tel: +46 (0)70 262 63 90
https://news.cision.com/sivers-semiconductors/r/bulletin-from-sivers-semiconductors-ab--publ-s-annual-general-meeting-on-25-may-2023,c3774015
https://mb.cision.com/Main/11695/3774015/2084741.pdf
(c) 2023 Cision. All rights reserved., source